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Depression is a mental illness that presents alterations in brain connectivity in the Default
Mode Network (DMN), the Affective Network (AN) and other cortical-limbic networks, and
the Cognitive Control Network (CCN), among others. In recent years the interest in the
possible effect of the different antidepressant treatments on functional connectivity has
increased substantially. The goal of this paper is to conduct a systematic review of the
studies on the relationship between the treatment of depression and brain connectivity.
Nineteen studies were found in a systematic review on this topic. In all of them, there
was improvement of the clinical symptoms after antidepressant treatment. In 18 out of
the 19 studies, clinical improvement was associated to changes in brain connectivity.
It seems that both DMN and the connectivity between cortical and limbic structures
consistently changes after antidepressant treatment. However, the current evidence
does not allow us to assure that the treatment of depression leads to changes in the
CCN. In this regard, some papers report a positive correlation between changes in brain
connectivity and improvement of depressive symptomatology, particularly when they
measure cortical-limbic connectivity, whereas the changes in DMN do not significantly
correlate with clinical improvement. Finally, some papers suggest that changes in
connectivity after antidepressant treatment might be partly related to the mechanisms
of action of the treatment administered. This effect has been observed in two studies
with stimulation treatment (one with rTMS and one with ECT), and in two papers that
administered three different pharmacological treatments. Our review allows us to make
a series of recommendations that might guide future researchers exploring the effect of
anti-depression treatments on brain connectivity.
Keywords: depression, depression treatment, brain connectivity, fMRI, antidepressants
INTRODUCTION
Major Depressive Disorder (MDD) and other depressive mood disorders present numerous
structural and functional alterations of the encephalon associated both to the physiopathology of
depression and its diverse symptomatic manifestations (Rogers et al., 2004; Fitzgerald et al., 2014;
Wise et al., 2014). Thus, depressive syndromes have been consistently related to reductions in brain
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volume in several areas related to the regulation of mood such as
the anterior cingulate cortex (ACC), along with certain regions
from the medial prefrontal cortex (mPFC), e.g., the orbitofrontal
cortex (OFC) and the ventromedial cortex (vmPFC). Reductions
have also been found in the volume of the lateral prefrontal cortex
(LPFC), the basal ganglia, and the hippocampus, among other
structures (Wise et al., 2014).
Likewise, functional Magnetic Resonance Imaging (fMRI)
allowed us to spot differences in the activation of these and
other brain areas, so that, in depressive symptoms, we find—
rather consistently—an increase in the activation of the mPFC,
the amygdala, and the hippocampus in depressed subjects with
respect to the control subjects (Rose et al., 2006; Siegle et al.,
2007; Wise et al., 2014). It is likewise common for depressed
patients to show fewer activations than healthy persons on the
LPFC, the inferior parietal lobe (BA 40), the posterior cingulate
cortex (PCC), and the striatum, among other structures (Rose
et al., 2006; Siegle et al., 2007; Wise et al., 2014).
Most fMRIs on depression compare the activation found in
the cerebral regions above mentioned, among others, to that
observed in healthy persons (Chen et al., 2008). However, in
recent years, the studies on functional and effective connectivity
have revealed that the several brain structures related to behavior
do not work in isolation, but they form complex functional
integration networks (Friston, 2011). Thus, the brain structures
altered in depression are part, in turn, of several connectivity
networks. Although the different papers on connectivity in
depression sometimes show contradictory results, most of the
evidence in the literature suggests that, in MDD, connectivity
networks at rest and the connectivity networks activated during
specific tasks are all altered (Wang et al., 2012). Accordingly,
affective disorders have been linked to alterations of the Default
Mode Network (DMN), the Affective Network (AN), the Salience
Network (SN), and the Cognitive Control Network (CCN),
among others (Dutta et al., 2014).
DMN is a network that becomes active when we are not
conducting complex cognitive tasks. DMN includes frontal
areas such as the ventromedial prefrontal cortex (vmPFC) and
portions of the anterior cingulate cortex (ACC), and from the
orbitofrontal cortex (OFC) and parietal areas like the posterior
cingulate cortex (PCC) and the medial, lateral, and inferior
parietal cortex (Raichle et al., 2001; Greicius et al., 2003). It
has been linked to self-reference processes and their alteration;
while the pathological interactions of DMN with other networks
such as the SN and the CCN would be linked to the states
of pathological rumination frequently presented by depressed
patients (Broyd et al., 2009; Belleau et al., 2014; Jacobs et al.,
2014). It is undoubtedly the most widely studied network in
mood disorders and the studies generally show that DMN is
hyperactivated in depressed patients (Greicius et al., 2007; Liston
et al., 2014). Nevertheless, some papers report the opposite
pattern in MDD (Veer et al., 2010; see Wang et al., 2012
for a review), and some studies report hyperactivation and
hypoactivation patterns at the same time between different
structures within DMN (Wu et al., 2011).
The AN is formed by connections between the ACC, the
amygdala, the hypothalamus, and other limbic structures. It has
also been reported as altered in MDD (Sheline et al., 2010;
Salomons et al., 2014), and since its alterations are involved in
hunger, sleep, and sexual conduct, it has been related to the
presence of vegetative symptoms in depression (Sheline et al.,
2010). It has also been found that depression could present
patterns of hypoconnectivity between cortical-limbic structures
when the brain is actively processing affective information
(Anand et al., 2005; Chen et al., 2008).
The CCN is formed by frontal areas, specifically the
dorsolateral prefrontal cortex (DLPFC) and the dorsal anterior
cingulate cortex (dACC), and parietal posterior areas, mostly the
posterior cingulate cortex (PCC). It is involved in the top-down
or goal-directed regulation of attention and in the regulation
of working-memory (Corbetta and Shulman, 2002) and it also
includes medial temporal lobe parts (Greicius et al., 2009). This
network becomes impaired in depression (Rogers et al., 2004;
Fales et al., 2008). Some studies show that depressed patients
present less connectivity in this network than control subjects
(Aizenstein et al., 2009; Liston et al., 2014).
Further evidence suggests that, in depressive disorders,
there are alterations of functional connectivity at rest between
structures that are part of different networks, as well as in
coupling them. For example, the alteration of connectivity
between cortical-limbic structures such as the connection
between the amygdala and ACC, and the amygdala and
DLPFC, among others, has been related to the cognitive
biases and neuropsychological alterations of depression (Thomas
and Elliott, 2009). It has likewise been suggested that the
hyperconnectivity of DMN and the SN with CCN is related
to rumination in depression (Jacobs et al., 2014). In addition
to the studies of the networks at rest in patients with MDD,
further anomalies have been described in brain connectivity,
such as alterations in cerebellum-brain connectivity in depressed
patients (Guo et al., 2013), or alterations in the inter-
hemispheric functional coordination related to disturbances in
the connectivity between both cerebral hemispheres (Wei et al.,
2014). Likewise, alterations of the connectivity in the affective
network (AN) have been reported in depressed patients, as well
as between cortical-limbic structures in emotional processing
paradigms in depression (Anand et al., 2005; Chen et al.,
2008; Delaveau et al., 2011). In addition, a recent meta-
analysis by Kaiser et al. (2015) included 27 seed-based voxel-
wise connectivity studies in MDD. That study confirmed the
alterations in the connectivity of both rest networks and in
network coupling. More specifically, it concluded that this
illness is characterized by several connectivity alterations in both
networks and in network coupling. More specifically, patients
with MDD presented hypoconnectivity within the frontoparietal
network, hypoconnectivity between frontoparietal systems and
parietal areas of the dorsal attention network, hyperconnectivity
within the DMN, and hyperconnectivity between frontoparietal
control areas and regions of the default network (Kaiser
et al., 2015). The authors also provided a model in which the
widespread network dysfunction underlies core affective and
cognitive alterations in MDD (Kaiser et al., 2015).
Given the generalized alterations of brain connectivity in
depression, in recent years there has been substantially increasing
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interest in the possible effect of the different antidepressive
treatments on functional connectivity in this illness, although this
phenomenon has been much less studied. Studies on functional
neuroimaging show that antidepressive treatment is capable
of normalizing brain activations in depressed patients during
affective tasks in areas such as DLPFC, Dorsomedial Prefrontal
Cortex (DMPFC), and ventrolateral Prefrontal Cortex (VLPFC),
among others (Delaveau et al., 2011). Moreover, a recent meta-
analysis by Ma (2014) studied the effects of antidepressants on
brain activity underlying emotional processing. Their results
showed that antidepressant treatments had effects on the
activation of limbic core structures such as the amygdala, the
thalamus, and ACC, and in other emotional processing structures
like MPFC, the insula, and the putamen. Antidepressant
medication increased the activity of these structures when
the subjects processed positive emotions, whereas the same
medication decreased the activity of the same structures
while processing negative emotions. For these reasons, it is
perfectly plausible to expect that, after the same treatments, the
depressed patients will present changes in connectivity related
to illness improvement. Accordingly, there is increasing interest
in knowing the effect of antidepressants and other somatic
treatments for depression on brain connectivity.
The goal of this review is to conduct a systematic review of
the studies focusing on the relationship between the treatment
of depression and brain connectivity to try to identify some
common patterns. Accordingly, we will review the changes
in brain connectivity that occur in DMN and CCN after
antidepressant treatment, and the changes among other cortical-
limbic connections in studies at rest and in studies of activation
during emotional tasks. Likewise, we will review some papers
measuring changes in connectivity in other brain structures.
Additionally, we will review, where possible, the relationship
between changes in brain connectivity and clinical improvement
observed after antidepressive treatment. To conclude, and also
where possible, we will review the possible “causal” relationships
between the type of treatment administered and the specific
connectivity changes observed when using a particular treatment
in MDD.
MATERIALS AND METHODS
Article Selection
The articles were selected after a search in the following
databases: Pubmed, Psychinfo, and Google Scholar. To locate
the papers, the following keywords were searched: “depression
treatment,” “connectivity,” and “fMRI” or “functional Magnetic
Resonance Imaging.” The term “depression treatment” was
replaced by “unipolar depression treatment” and “major
depressive disorder treatment” and the previous terms were
combined with the Boolean link “and” in several bibliographical
searches. Such process was conducted by two independent
researchers who reproduced the paper selection process. The
initial level of agreement was of 98% and they concurred the
decision to include or not they articles on which they disagreed.
That same term was also replaced by all the existing
second-generation antidepressants, and each antidepressant was
combined with the other keywords. Out of all the articles
recovered, their suitability was assessed for the goals of the
current paper on the base of the selection criteria below.
The studies had to contain a sample of patients with one or
more active depressive syndromes that had been treated with
at least one standard depression treatment: antidepressants,
Electroconvulsive Therapy (ECT), or psychotherapy. We also
included those treated with the experimental treatment repetitive
Transcranial Magnetic Stimulation (rTMS), due to its increasing
use. The papers had to take, at least, two fMRI measures in
the group of depressed patients, one before and the other
after finishing the antidepressive treatment. Under these criteria,
and in an early stage, 92 different articles were found in the
different databases, once duplicities had been spotted in each
database. Out of the articles identified, we deleted those not
bearing empirical evidence on one connectivity network linked
to MDD. Thirty-six papers were then discarded (39.13%) as
they mentioned the topic tangentially. Out of the remaining
papers (56), we deleted those that only presented the correlations
matrices but not specific connectivity models, given their strictly
descriptive goal, regardless of considerations on functional
or structural connectivity. Under this criterion, we deleted
26 further papers (28.26%). We analyzed the remaining 30
individually, and we discarded those not offering all the
information on the connectivity model, or where such model
was partial. This way, we deleted 10 more papers (10.86%
of the total), and thus there remained 20 papers suitable for
analysis. Eventually, one of them was discarded because the
connectivity data were duplicated in a previous publication.
Accordingly, there remained a total of 19 articles measuring
changes in brain connectivity in depressed patients before and
after treatment. The following flow chart shows this selection
process of articles analyzed, which carry the symbol ∗ in the
bibliography (Figure 1).
Once the selection process was finished, both researchers
conducted the selection of information from each paper and
obtained, eventually, a 100% agreement on the data of each paper
analyzed.
RESULTS
After searching and applying the criteria, we found 19
articles measuring changes in brain connectivity associated to
antidepressive response (Anand et al., 2005; Chen et al., 2008;
Aizenstein et al., 2009; Lisiecka et al., 2011; Wu et al., 2011;
Beall et al., 2012; Perrin et al., 2012; Abbott et al., 2013, 2014;
Andreescu et al., 2013; Heller et al., 2013; Li et al., 2013; Posner
et al., 2013; Baeken et al., 2014; Liston et al., 2014; Salomons et al.,
2014; Wang et al., 2014; Wei et al., 2014; Yang et al., 2014).
Clinical Results
Out of the 19 studies analyzed, 11 were conducted on patients
with MDD (Anand et al., 2005; Chen et al., 2008; Lisiecka et al.,
2011; Beall et al., 2012; Abbott et al., 2013, 2014; Heller et al.,
2013; Li et al., 2013; Liston et al., 2014; Salomons et al., 2014;
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FIGURE 1 | Flow chart of the paper selection process.
Wang et al., 2014). Three studies were conducted on patients
with a MDD diagnosis, but in the Late-onset Depression variant
(LOD) (Aizenstein et al., 2009; Wu et al., 2011; Andreescu et al.,
2013). One was conducted on dysthymic patients (Posner et al.,
2013), one on patients with a “unipolar depression” diagnosis
(Yang et al., 2014), two on patients with a “severe depression”
diagnosis (Perrin et al., 2012; Baeken et al., 2014), and one on
patients with “diagnosis of depression” (Wei et al., 2014). None of
the studies were conducted on depressive-stage bipolar patients
although one study included 4 patients with that diagnosis in its
21-participant sample (Liston et al., 2014), and another included
an unspecified number of bipolar patients out of a total of 6
participants (Beall et al., 2012).
With regard to the treatments administered, 11 studies
administered antidepressant treatments (Anand et al., 2005;
Chen et al., 2008; Aizenstein et al., 2009; Lisiecka et al.,
2011; Wu et al., 2011; Andreescu et al., 2013; Heller et al.,
2013; Li et al., 2013; Posner et al., 2013; Wang et al., 2014;
Yang et al., 2014). The duration of the treatments varied,
ranging from 4 weeks (Lisiecka et al., 2011) to 12 weeks
(Aizenstein et al., 2009; Andreescu et al., 2013; Li et al.,
2013). In the 11 studies where an antidepressant treatment was
administered, it was successful, so the depressive symptoms
were reduced or remitted in the majority of the patients. This
and further relevant clinical information has been summarized
in Table 1.
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Out of the 18 papers analyzed, 5 of them studied connectivity
after ECT (Beall et al., 2012; Perrin et al., 2012; Abbott et al.,
2013, 2014;Wei et al., 2014). The treatment was administered in a
number of sessions ranging from an average of 7 (Wei et al., 2014)
to 11 (Abbott et al., 2013, 2014). All the papers with low numbers
show that the treatment was administered efficiently, and that the
response or remission of depressive symptoms was achieved in
the majority of patients. Three papers used rTMS as a depression
treatment (Baeken et al., 2014; Liston et al., 2014; Salomons
et al., 2014). In these papers, 25 and 20 rTMS sessions were
administered, respectively. All the papers obtained a response
or a partial response to such antidepressive therapy. This and
further relevant clinical information has been summarized in
Table 2.
Connectivity Results
Out of the 18 studies, 12 had a “longitudinal case-control study”
design (Anand et al., 2005; Chen et al., 2008; Aizenstein et al.,
2009; Wu et al., 2011; Abbott et al., 2013, 2014; Andreescu et al.,
2013; Heller et al., 2013; Li et al., 2013; Liston et al., 2014;
Wang et al., 2014; Wei et al., 2014). Out of these, however, the
paper by Heller et al. (2013) reports pre-post results only for
the behavioral data. One paper had a Mixed-factorial design
with two treatment groups (Lisiecka et al., 2011). One combined
a mixed factorial design with placebo-controlled clinical trial
methodologies (Posner et al., 2013), and one had a sham-
controlled cross-over design (Baeken et al., 2014). The remaining
works were conducted with a pre- and post-treatment design
(Beall et al., 2012; Perrin et al., 2012; Salomons et al., 2014;
Yang et al., 2014). According to the type of paradigm, out of
the 11 papers that administered antidepressant treatments, 6
assessed connectivity at rest (Wu et al., 2011; Andreescu et al.,
2013; Li et al., 2013; Posner et al., 2013; Wang et al., 2014;
Yang et al., 2014), 4 assessed brain connectivity using different
activation paradigms (Chen et al., 2008; Aizenstein et al., 2009;
Lisiecka et al., 2011; Heller et al., 2013), and one work used
both approaches (Anand et al., 2005). Out of the 8 works that
treated patients with somatic non-pharmacological treatments,
7 were performed at rest (Perrin et al., 2012; Abbott et al.,
2013, 2014; Baeken et al., 2014; Liston et al., 2014; Salomons
et al., 2014; Wei et al., 2014) and one paper used emotional
and cognitive paradigms and resting measures (Beall et al.,
2012).
These and further methodological characteristics have been
summarized in Tables 3A,B, 4A,B.
As regards the studies’ results on connectivity, seven studies
approached the effect of depression treatment on DMN
connectivity (Wu et al., 2011; Beall et al., 2012; Abbott et al.,
2013; Andreescu et al., 2013; Li et al., 2013; Posner et al.,
2013; Liston et al., 2014). Four studies (Andreescu et al., 2013;
Li et al., 2013; Posner et al., 2013; Liston et al., 2014) found
DMN hyperconnectivity in depressed patients with respect to
the control subjects. In all of them, connectivity reductions
were observed in DMN after the treatment (Li et al., 2013;
Posner et al., 2013; Liston et al., 2014), except for the paper
by Andreescu et al. (2013), where—somewhat paradoxically—
it was associated to an increased connectivity in the anterior,
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frontal nodes of the DMN, in which such “frontalization” is
interpreted as a possible normalizing effect of antidepressant
treatment. The paper by Abbott et al. (2013) suggested that
patients with MDD present a hyperconnectivity pattern in the
posterior areas of DMN, PFDLC, and dmCPF, which tends to
recover after the treatment. The paper by Wu et al. (2011)
showed a mixed pattern of hypoconnectivity in the posterior
areas of DMN, and hyperconnectivity in the most anterior
areas of the same network at rest in depressed patients. In
the same paper, hypoconnectivity between PCC and sgACC
recovered, but not PCC-dmPFC hyperconnectivity (Wu et al.,
2011). The paper by Beall et al. (2012), with a pre- and post-
treatment design, showed an increase in PCC-ACC connectivity
after ECT treatment. Four studies investigated the possible
correlation between clinical improvement of depression and
changes in connectivity (Beall et al., 2012; Abbott et al., 2013;
Li et al., 2013; Posner et al., 2013). Only the study by Beall
et al. (2012) found that clinical improvement correlated with
changes in ACC-DLPFC connectivity. The other papers found
no correlations between clinical symptom improvement and
changes in connectivity (Abbott et al., 2013; Li et al., 2013; Posner
et al., 2013). The specific results from each study have been
summarized in Tables 3A,B, 4A,B.
Six studies approached the changes in connectivity after
depression treatment in cortical-limbic connectivity, one of them
conducted at rest (Salomons et al., 2014), and the others using
several affective tasks (Anand et al., 2005; Chen et al., 2008;
Lisiecka et al., 2011; Beall et al., 2012; Heller et al., 2013). Two
of them compared the connectivity between ACC, frontal and
limbic regions of depressed patients with control patients at the
baseline measure. Both presented similar results. On the one
hand, the one by Anand et al. (2005) found hypoconnectivity
between ACC and the subcortical structures such as the
medial thalamus and the pallidostriatum. On the other, Chen
et al. (2008) found a pattern of hypoconnectivity between the
amygdala and several cortical and subcortical structures (Chen
et al., 2008). Likewise, both papers found important increases
in connectivity after the treatment. In the paper by Anand
et al. (2005) no differences in connectivity were found after
the treatment between the patients and the control subjects
at rest and when exposed to negative stimuli (visual images
with negative affective valence from “The International Affective
Picture System”; IAPS). It has also been suggested that the
amygdala connectivity becomes normalized after antidepressive
treatment (Chen et al., 2008).The paper by Lisiecka et al. (2011)
compared the changes in brain connectivity between two groups
of depressed patients, one treated with venlafaxine and the other
with mirtazapine. After the treatment, the patients presented
increases in connectivity between dmPFC and cerebellum,
cingulated cortex, parietal cortex, and decreases in connectivity
between the OFC and the right medial cingulated cortex, the
middle temporal gyrus, the superior occipital gyrus, the right
fusiform gyrus, and the inferior temporal gyrus. Also the same
paper showed decreases in connectivity between left the OFC
and the left superior parietal gyrus, the pre-cuneus, and the
post-central gyrus, the left medial temporal gyrus, the cuneus,
the calcarine fissure, and the angular gyrus (Lisiecka et al.,
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2011). This study also suggested that venlafaxine changed the
OFC-cerebellum coupling, whereas mirtazapine increased the
OFC-DLPFC connectivity. Three studies measured changes in
brain connectivity after antidepressant treatment in a pre- and
post-treatment design (Beall et al., 2012; Heller et al., 2013;
Salomons et al., 2014). The work by Beall et al. (2012) found a
pattern of increases and decreases in connectivity between ACC,
the caudate nucleus and frontal and parietal cortical areas. The
work by Salomons et al. (2014) showed—among other findings—
decreases in connectivity between dmPFC and some limbic
structures. The work by Heller et al. (2013) found connectivity
between the nucleus accumbens, MFG and accumbens-VMPFC
related to changes in affection. Out of all these papers, four of
them (Anand et al., 2007; Beall et al., 2012; Heller et al., 2013;
Salomons et al., 2014) conducted analyses of the correlations
between connectivity changes and the improvement of depressive
symptoms measured through clinical scales (Anand et al., 2007;
Beall et al., 2012; Salomons et al., 2014), or correlations between
changes in connectivity and specific symptoms improvement,
such as alterations of affection or anhedonia (Heller et al., 2013).
The four papers found a positive link between both types of
variables. Each paper’s specific results have been summarized in
Tables 3A,B, 4A,B.
Three papers studied changes in connectivity in CCN after
depression treatment (Aizenstein et al., 2009; Perrin et al., 2012;
Liston et al., 2014). In the first paper, the authors found that
depressed patients showed less connectivity between DLPFC and
dACC than control subjects (Aizenstein et al., 2009). The paper
by Liston et al. (2014) found hypoconnectivity in depressed
patients between DLPFC and MFG (BA 46), posterior parietal
areas, and other prefrontal areas (Liston et al., 2014). In none of
the studies was connectivity recovered after depression treatment
(Aizenstein et al., 2009; Liston et al., 2014), although the study
by Liston et al. (2014) did find improvement after treatment
in DMN. The paper by Perrin et al. (2012) suggested that
patients experienced reductions in connectivity related to the
treatment within l_DLPFC and the prefrontal cortex (BA 44,
45, and 46) as well as reductions in connectivity between ACC
and areas of OFC and r-DLPFC among others (Perrin et al.,
2012). Each paper’s specific results have been summarized in
Tables 3A,B, 4A,B.
Lastly, six papers could not be classified into the above
division. The paper by Abbott et al. (2014) suggested that
depressed patients show hypoconnectivity of each hippocampus
with the contralateral medial temporal lobe and of r_HPC
with ACC. In this study, after the treatment, only the right
hippocampus connectivity increased, which the authors attribute
to the hemisphere where ECT was applied (Abbott et al.,
2014). Moderate correlations were reported in this paper
between connectivity recovery and clinical improvement. On
the other hand, the paper by Wei et al. (2014) suggested
that depressed patients present hypoconnectivity in the Voxel
Mirrored Homotopic Connectivity between both MFG (BA
8/9) and both angular gyri (BA 49). The paper also suggested
that, after treatment, the connectivity between both hemispheres
increases and tends to become normalized (Wei et al.,
2014).The paper by Wang et al. (2014) suggested that depressed
patients show smaller Functional Connectivity Strength maps
(FCS) than healthy subjects in both hippocampi, and the
opposite pattern in the dmPFC cortexes of both hemispheres.
Antidepressant treatment tended to reverse the pattern so
that, after treatment, FCS increased between both hippocampi
and it decreased between dmPFCs. Additionally, the changes
in dmPFC connectivity correlated positively with the clinical
improvement measures (Wang et al., 2014). In the paper by
Yang et al. (2014), we observed increases in the connectivity of
the hypothalamus with temporal areas and of the basal ganglia,
and decreases of the connectivity of the hypothalamus with
frontal and medial areas, the thalamus, and the cerebellum
(Yang et al., 2014). The work by Baeken et al. (2014) found
that the successful depression treatment with high frequency
rTMS was associated to an increase in connectivity between
sgACC and perigenual ACC, both seeds of either DMN
and AN. Each paper’s specific results are summarized in
Tables 3A,B, 4A,B.
DISCUSSION
The goal of the current paper is to review the studies investigating
the effect of antidepressant treatment on brain connectivity.
Some conclusions may be extracted from the current review.
Firstly, out of the 19 papers reviewed, all but one (Aizenstein
et al., 2009) reported that, after depression treatment and
the corresponding improvement, there occur changes in brain
connectivity. As can be observed in Tables 1, 2, despite the
fact that most of the studies were conducted on patients with
MDD (Anand et al., 2005; Chen et al., 2008; Lisiecka et al.,
2011; Beall et al., 2012; Abbott et al., 2013, 2014; Heller
et al., 2013; Li et al., 2013; Liston et al., 2014; Salomons
et al., 2014; Wang et al., 2014), depression treatment is also
related to changes in connectivity in patients with LOD (Wu
et al., 2011; Andreescu et al., 2013), in dysthymic patients
(Posner et al., 2013), and in more heterogenic samples of
patients with unipolar depression (Perrin et al., 2012; Wei
et al., 2014; Yang et al., 2014). Likewise, several of these papers
include, among their samples, treatment-resistant patients, or
ones with comorbid anxiety disorders among other clinical
characteristics. Accordingly, successful treatment of unipolar
depression seems to be generally related to changes in brain
connectivity.
As regards the connectivity networks studied in the current
paper, the results summarized in Tables 3A,B, 4A,B allow us
to conclude that both depression and depression improvement
are related to changes in connectivity in DMN as all the papers
included in this review find this association positive (Wu et al.,
2011; Beall et al., 2012; Abbott et al., 2013; Andreescu et al., 2013;
Li et al., 2013; Posner et al., 2013; Liston et al., 2014). Most of
these papers found basal a hyperconnectivity pattern in the DMN
of depressed patients—already discussed in the Results Section—
except for the paper by Abbott et al. (2014), where a different
pattern was found. This hyperconnectivity pattern in DMN is
to be expected given that—as discussed in the introduction—it
is a common finding in most studies and was confirmed in a
recent meta-analysis (Kaiser et al., 2015). It is an interesting fact
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that all the studies reviewed found changes in DMN connectivity
after treatment, and most studies found that DMN connectivity
tends to normalize or resemble more that of healthy subjects
after treatment (Wu et al., 2011; Abbott et al., 2013; Andreescu
et al., 2013; Li et al., 2013; Posner et al., 2013; Liston et al., 2014).
However, most studies—except for Abbott et al. (2013) maybe—
suggested that the normalization of DMN connectivity after
treatment is incomplete. In the paper by Andreescu et al. (2013),
the antidepressant treatment was associated to an increased
connectivity in the anterior frontal nodes of the DMN, but the
alterations of PCC connectivity found in their depressed patients
prior to treatment was not recovered. In the paper by Liston
et al. (2014), the treatment was associated to a decrease in sgACC
connectivity with other DMN structures, but the connectivity of
pgACC with the thalamus and the pre-cuneus did not change.
Something similar may be concluded from the studies
measuring connectivity changes between cortical-limbic
structures (Anand et al., 2005; Chen et al., 2008; Lisiecka et al.,
2011; Beall et al., 2012; Heller et al., 2013; Salomons et al.,
2014). In fact, in all these papers, the patients showed changes
in connectivity between different cortical and limbic structures
after depression treatment. According to the emotional valence
of the stimulus, the papers by Anand et al. (2005) and Heller
et al. (2009) showed similar results given that, in both papers,
structures that are critical to emotional processing such as
ACC and AMY present hypoconnectivity in depressed patients
when compared to healthy ones in situations of negative
emotions processing. More importantly, their data suggests that
antidepressant treatment tends to normalize the connectivity in
these structures (Anand et al., 2005; Chen et al., 2008). The paper
by Beall et al. (2012) showed that ECT treatment diminished
the activity of OFC when faced with negative valence stimuli.
Nevertheless, the connectivity analysis of this paper was made
only for the rest condition, and the authors found the hyper and
hypoconnectivity mixed pattern of the OFC that is described in
Table 4B (Beall et al., 2012), which is difficult to interpret due to
the methodology used in that study. The paper by Heller et al.
(2013) focuses on positive emotional processing. A previous
study not included in this meta-analysis—(Heller et al., 2009)—
showed that depressed patients had difficulty in sustaining the
connectivity between the nucleus accumbens and the DLPFC
when they were instructed to enhance positive emotions elicited
by positive images. In the paper included in our review, its data
suggests that antidepressant treatments improved sustained
connectivity between the nucleus accumbens and vmPFC when
patients performed the same kind of task, and these gains were
related to gains in positive affect after treatment (Heller et al.,
2013). The work by Lisiecka et al. (2011) is difficult to discuss
in terms of the emotional valence of the stimulus because the
authors performed an OFC seed-whole brain connectivity
analysis and found a very complex pattern of OFC connectivity
changes that is hardly interpretable in terms of functional
connectivity related to the emotional valence processing. Finally
the paper by Salomons et al. (2014) showed that a successful
treatment was associated with increased dmPFC-thalamic
connectivity and decreased sgACC-caudate connectivity.
Although performed at rest, it should be noted that, in their
study, these changes strongly correlated with improvements in
depressive symptoms. In other studies, sgACC connectivity with
striatal regions has been related to the maladaptive emotion
regulation of depressed patients (Furman et al., 2011). Therefore,
the connectivity changes in the paper by Salomons et al. (2014)
were possibly somewhat related to changes in positive or
negative emotional processing. Taken together, the results of our
review resembles to some extent those of Ma (2014), because
successful antidepressant treatment may be associated to both
activation and connectivity changes in different emotional sub-
networks during emotional negative processing, and probably
also during positive emotional experiences. However, the
number of connectivity studies performed to date is too small to
establish the specific connectivity modifications after depression
treatment.
Nonetheless, it is not clear that the same thing happens with
the connectivity of the Cognitive Network structures since, out
of the three papers studying this network (Aizenstein et al., 2009;
Perrin et al., 2012; Liston et al., 2014), only one reports a positive
relationship between connectivity changes and depression
improvement (Perrin et al., 2012), whereas longitudinal-case
control studies show more permanent alterations in this
network. Although by no means does this allow us to
conclude that CCN is a treatment-resistant network, it is
noteworthy that it is the only network yielding this type
of result. It is even more noteworthy if we consider that,
in addition to the papers on DMN and cortical-limbic
connections, there exist reports on the positive relationship
between depression improvement and connectivity changes in
the hippocampus (Abbott et al., 2013), the hypothalamus (Yang
et al., 2014), between both brain hemispheres (Wei et al.,
2014), between sgACC and perigenual ACC (Baeken et al.,
2014), and in studies conducted with connectivity analyses of
the whole brain (Wang et al., 2014). Undoubtedly, further
studies are needed to find out what happens to CCN after
treatment.
We find positive correlations between clinical improvement
and changes in brain connectivity in three papers investigating
cortical-limbic connectivity changes (Anand et al., 2007; Heller
et al., 2013; Salomons et al., 2014): one investigates connectivity
changes between HPC and dmPFC and the rest of the brain
(Wang et al., 2014); and then the paper by Beall et al.
(2012), which was conducted with seeds belonging to DMN
and the limbic system. However, the papers investigating the
relationship between depression treatment and connectivity
changes in DMN found no such association (Abbott et al.,
2013; Li et al., 2013; Posner et al., 2013). Taken together, the
data suggest the possibility of a relationship between recovery
from depression symptoms and recovery of connectivity between
several cortical-limbic structures. The close relationship between
clinical recovery and connectivity changes between these brain
areas may be somewhat expectable because the limbic system is
closely related to the mood, anxiety, and vegetative symptoms
that constitute the core depressive symptoms. However, the
lack of a relationship between clinical improvement and
changes in connectivity in DMN might be expectable given
that DMN would be related to rumination but not to core
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depression symptomatology as indexed in the HAM-D scale
(Posner et al., 2013). Interestingly, the paper by Beall et al.
(2012) found a correlation between depression symptoms
improvement and rACC-rDLPFC connectivity. Given that other
studies measuring connectivity between other networks also
find this type of correlation (Abbott et al., 2014; Wang
et al., 2014), this phenomenon should be studied in more
depth.
Finally, we would like to mention that some papers hint at
the existence of a causal relationship between recovery from
depression symptoms and specific changes in brain connectivity.
For example, the paper by Salomons et al. (2014)—where rTMS
sessions were applied on dmPFC as a depression treatment—
found post-treatment changes between dmPFC and other limbic
structures. The paper by Abbott et al. (2014) found post-
treatment changes in connectivity in the right hemisphere,
which is attributed to the fact that the ECT sessions were
mostly applied on the right side and unilaterally (Abbott et al.,
2014). Interestingly, the paper by Liston et al. (2014) applied
rMTS sessions to DLPFC but found no changes in connectivity
in CCN. The paper by Heller et al. shows that treatment
with duloxetine was related to changes in connectivity in
DMN, but the same thing did not happen with the placebo
group. Some papers suggest that some specific changes in
connectivity after depression treatment might depend, partly, on
the specific pharmacological treatment administered (Lisiecka
et al., 2011), although the paper by Heller et al. (2013) found
no differences between treatment groups in the correlation
between changes in the connectivity of BA 46 and the positive
affection improvement among its depressed patients. Therefore,
the selection of papers suggests that part of the changes
in brain connectivity experienced after depression treatment
might depend—partly, at least—on the mechanisms of action
of the treatment administered. This, in turn, would not only
bear important clinical implications, but it would also open
the door for the use of connectivity as a tool to study the
mechanisms of action and therapeutic of several depression
treatments.
The current paper has some limitations, too, namely the
fact that it is a systematic review but not a meta-analysis. The
number of studies and their heterogeneity advised us against the
latter type of study. In addition, the number of papers that can
be included in the review, the variety in research designs, and
the variety of treatments administered among other variables
render it very difficult to build a conclusive model on brain
connectivity related to depression treatment. Therefore, we are
unable to build an integrative model about the changes in brain
connectivity after depression treatment. For these reasons, the
conclusions of this paper should be considered as preliminary.
Another limitation of the present work is the publication bias that
usually occurs in fMRI studies (Jennings and Van Horn, 2012). In
fact, disregarding reports as that from Aizenstein et al. (2009),
researches in which positive association between successful
antidepressant treatment and changes in brain connectivity could
not be demonstrated might remain unpublished. Indeed, this
and other relevant aspects could bias our review. Nevertheless,
the paper also has some strength. To our knowledge, it is the
only paper to review systematically treatment-related changes in
brain connectivity measured through fMRI, and we can offer
a few preliminary conclusions on the relationship between the
treatment of depression and changes in brain connectivity. They
are listed below.
The somatic treatment of depressive symptoms seems to
be associated generally to changes in brain connectivity. As
for DMN, in most of the studies included, it was found
that this network is hyperactive in depressed patients, and
that the treatment tends to normalize DMN hyperconnectivity.
However, this normalization is usually incomplete, and the
frontal portions of DMN might probably still present alterations
of connectivity after treatment. The connectivity of cortical-
limbic connections related to the emotional processing also
changes after depression treatment. The studies suggest that a
successful antidepressant treatment would be linked to changes
in the connectivity of different sub-networks involved in negative
emotional processing, and possibly also in the processing of
positive emotions. Current data suggests that CCN might not
undergo changes after a successful antidepressive treatment.
In a rather consistent way, changes in connectivity between
cortical-limbic structures correlate with an improvement of
the core depressive symptoms. However, there seems to be
no link between changes in the connectivity of DMN after
antidepressive symptom and the improvement of the clinical
symptoms of the condition. Lastly, we should point out that
some papers hint at the existence of a causal relationship between
recovery from depression symptoms and specific changes in
brain connectivity, and also that depression treatment might
depend—partly, at least—on the mechanisms of action of the
treatment administered, which would have important theoretical
and clinical implications.
Another strength of our work is the fact that it allows us to
make a series of recommendations that, on the one hand, it might
guide future researchers exploring the effect of anti-depression
treatments on brain connectivity and, on the other, they would
help to report some of the data of this type of study to improve its
scientific quality.
1. Presenting complete sociodemographic data: As can be seen
in Tables 1, 2, in various papers, these data are not sufficiently
reported. However, they are essential to understand the nature
of the sample on which the study was conducted.
2. Reporting the data related to the psychopathology and the
psychopathological evaluation of the patients: Some of the
studies comprised in the current review only mention that
they had a depression, but the types of the patients’ depressive
disorders are not specified, nor are the criteria under which
they were diagnosed. In several papers, the data on the severity
of depressive symptomatology are incomplete. Sometimes
even essential data are missing, such as the standard deviation
of the Hamilton scale scores, before and after the treatment.
In addition, many papers do not report data on the possible
psychopathological comorbidities of the depressed patients.
It might be advisable to present all these data in the Results
Section of the articles for a better comprehension of the type
of sample used in each study.
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3. Increasing the types of clinical instruments used: In most of
the studies reviewed, the effect of anti-depression treatment
is measured through the Hamilton scale for depression
and, when trying to establish correlations among changes
in brain connectivity after antidepressant treatment, they
are often non-significant. However, this does not necessarily
mean that there is no relevant association between the
clinical improvement of specific symptoms of depression
and brain connectivity. For example, clinical scales such as
the Beck scale, which measures symptoms of rumination
among others, might show correlations between the possible
changes in DMN after the treatment and improvement of
clinical symptomatology. The study by Heller et al. (2013)
found correlations between changes in brain connectivity and
improvement of positive and negative affect. Nevertheless,
despite the fact that depression is an affective disorder,
affection scales are not commonly used to monitor clinical
change in depressed patients. These instruments along
with others—such as, for example, neuropsychological tests
that measure specific cognitive domains—should be used
if we mean to establish correlations between changes in
connectivity and clinical improvement.
4. Conducting, as far as possible, hypothesis-driven studies: In
the current review we can observe a few papers with data-
driven analyses, or where the correlations of one ROI with
the full brain were studied. The problem with these studies is
that data interpretation is complex and, logically, the authors
tend to discuss the part of the results most relevant to them,
while discarding another part of the results as possible “noise.”
The problem with this approach is that, as we mentioned in
the introduction, and as can be seen in Tables 3, 4, the brain
areas affected by depression are very diverse and, therefore,
this type of study runs the risk of not interpreting or not giving
relevance to changes in certain connectivity patterns after the
treatment of depression that might be important.
5. Using a control group to better establish the magnitude of
the change in connectivity. Pre- and post-studies allow us
to see whether there are changes in brain connectivity after
antidepressant treatment. However, in many of the studies,
there is no control group, which prevents us from knowing the
magnitude of alterations in brain connectivity and, therefore,
we cannot know whether brain connectivity—or to what
extent changes in brain connectivity after antidepressant
treatment—shows a tendency toward the recovery of the
connectivity of a healthy person. We should also bear in mind
that pre- and post-treatment designs tend to overestimate
the magnitude of connectivity changes after treatment.
Accordingly, the lack of a control group somewhat hinders the
interpretability of the data in terms of an effect size.
6. Using research designs that allow us to establish cause-effect
relationships: As we mentioned above, some studies suggest
the existence of a causal relationship between the treatment
of depression and changes in brain connectivity. However,
pre- and post-treatment designs are not the most suitable to
establish this type of relationship, given the lack of adequate
methodological control measures. It is suggested that, as far
as possible, these studies should compare treatments among
themselves, or else that short studies should be designed with
sham or placebo groups. However, the latter may be difficult,
as it would involve leaving a group of patients untreated,
which would be disputable from an ethical point of view
because these papers do not study the possible efficacy of the
treatments.
We are aware that the latter two points are, to some extent,
incompatible. Establishing a brain connectivity baseline and
trying to establish causal relationships between treatment and
changes in connectivity would involve, most of the time,
designing studies with more than two groups and their
corresponding follow-up. However, we do believe that, in
designing future studies, they should ideally either comprise
a control group, or choose a design that allows us to better
research the possible causal relationships between the effect of
treatment and changes in brain connectivity, like using two
arms of active treatment. The current review allows us to
establish that, generally, the treatment of depression is linked to
changes in brain connectivity. The two most relevant questions
to answer at the moment would be, on the one hand, whether
antidepressant treatment is linked to the recovery of normal
connectivity and to what extent, and on the other, whether
there is a cause-effect relationship between the treatment of
depression and the recovery of connectivity, or else if the link
between both phenomena is influenced by other variables. The
current state of the art does not allow us to identify bigger
matters or venture more complex hypotheses on this topic. This
paper clearly shows how, at the moment, a descriptive one is
the best methodological approach to review the contributions
of the estimations of brain connectivity models in the study
of the effectiveness of treatments related to MDD. This field
is no different from other similar ones, both medical and
psychological. For example, the situation resembles—to a great
extent—that which is perceived in disorders unrelated to the one
discussed here. For instance, papers on fMRI in type 1 diabetes
(Gallardo et al., 2015) show the same embryonic state as the
brain connectivity effects of depression treatment, we have noted.
Accordingly, the current state of affairs should be considered,
in our opinion, an undeniably relevant opportunity for scientific
breakthrough.
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